These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 15537052

  • 1. Development of anthrax DNA vaccines.
    Ferrari ME, Hermanson G, Rolland A.
    Curr Opin Mol Ther; 2004 Oct; 6(5):506-12. PubMed ID: 15537052
    [Abstract] [Full Text] [Related]

  • 2. [Progress on the vaccine for anthrax].
    Zhan DW, Wang P, Wang LC, Zhang ZS.
    Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):149-52. PubMed ID: 15847185
    [Abstract] [Full Text] [Related]

  • 3. Advances in the development of next-generation anthrax vaccines.
    Friedlander AM, Little SF.
    Vaccine; 2009 Nov 05; 27 Suppl 4():D28-32. PubMed ID: 19837282
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A, Hannaman D, Nolan E, Ellefsen B, Nakamura G, Chau L, Tellez O, Little S, Bernard R.
    Vaccine; 2008 Sep 19; 26(40):5216-22. PubMed ID: 18462850
    [Abstract] [Full Text] [Related]

  • 5. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN, Ulrich RG, Quesnel-Hellmann A, Mohamadzadeh M, Stiles BG.
    Expert Rev Anti Infect Ther; 2009 Mar 19; 7(2):219-36. PubMed ID: 19254170
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of a subunit vaccine against Bacillus anthracis.
    Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V.
    Vaccine; 2007 Apr 20; 25(16):3111-4. PubMed ID: 17280756
    [Abstract] [Full Text] [Related]

  • 7. DNA vaccines for biodefense.
    Dupuy LC, Schmaljohn CS.
    Expert Rev Vaccines; 2009 Dec 20; 8(12):1739-54. PubMed ID: 19943766
    [Abstract] [Full Text] [Related]

  • 8. Past, imminent and future human medical countermeasures for anthrax.
    Baillie LW.
    J Appl Microbiol; 2006 Sep 20; 101(3):594-606. PubMed ID: 16907809
    [Abstract] [Full Text] [Related]

  • 9. Anthrax vaccines.
    Friedlander AM, Welkos SL, Ivins BE.
    Curr Top Microbiol Immunol; 2002 Sep 20; 271():33-60. PubMed ID: 12224523
    [Abstract] [Full Text] [Related]

  • 10. II. Cationic lipid-formulated plasmid DNA-based Bacillus anthracis vaccine: evaluation of plasmid DNA persistence and integration potential.
    Vilalta A, Mahajan RK, Hartikka J, Leamy V, Martin T, Rusalov D, Bozoukova V, Lalor P, Hall K, Kaslow DC, Rolland A.
    Hum Gene Ther; 2005 Oct 20; 16(10):1151-6. PubMed ID: 16218776
    [Abstract] [Full Text] [Related]

  • 11. Molecular basis for improved anthrax vaccines.
    Brey RN.
    Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1266-92. PubMed ID: 15935874
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anthrax vaccines: a development update.
    Little SF.
    BioDrugs; 2005 Jun 17; 19(4):233-45. PubMed ID: 16128606
    [Abstract] [Full Text] [Related]

  • 16. DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components.
    Hahn UK, Boehm R, Beyer W.
    Vaccine; 2006 May 22; 24(21):4569-71. PubMed ID: 16157424
    [Abstract] [Full Text] [Related]

  • 17. [Development of a killed but metabolically active anthracis vaccine candidate strain].
    Shen F, Yuan S, Zhan D, Wang Y, Ren M, Tao H, Wang P, Wang L, Chen D, Liu C.
    Sheng Wu Gong Cheng Xue Bao; 2011 May 22; 27(5):781-9. PubMed ID: 21845845
    [Abstract] [Full Text] [Related]

  • 18. Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integration.
    Leckenby MW, Spear AM, Neeson BN, Williamson ED, Cranenburgh RM, Atkins HS.
    Microb Pathog; 2009 Apr 22; 46(4):201-6. PubMed ID: 19490834
    [Abstract] [Full Text] [Related]

  • 19. [PERSPECTIVES OF DEVELOPMENT OF LIVE RECOMBINANT ANTHRAX VACCINES BASED ON OPPORTUNISTIC AND APATHOGENIC MICROORGANISMS].
    Popova PY, Mikshis NI.
    Zh Mikrobiol Epidemiol Immunobiol; 2016 Apr 22; (1):79-89. PubMed ID: 27029122
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.